Cell Signaling Technology

DIDO1 Antibody

#3605 · $317

100
Citing papers
10.1k
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer8Genomics, phytochemicals, and oxidative stress6Ubiquitin and proteasome pathways6Autophagy in Disease and Therapy6Cytokine Signaling Pathways and Interactions5Cancer-related Molecular Pathways5Acute Myeloid Leukemia Research5Immune Cell Function and Interaction5

Papers citing this product

1
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Blood·2009·641 cit.·DOI
2
Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features
Clinical Cancer Research·2010·422 cit.·DOI
3
Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress
Science·2013·410 cit.·DOI
4
The molecular basis of IL-21–mediated proliferation
Blood·2007·311 cit.·DOI
5
Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3
Brain·2009·260 cit.·DOI
6
Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
Clinical Cancer Research·2009·230 cit.·DOI
7
Differentiation of Human Circulating Fibrocytes as Mediated by Transforming Growth Factor-β and Peroxisome Proliferator-activated Receptor γ
Journal of Biological Chemistry·2007·225 cit.·DOI
8
Selective Intracellular Release of Copper and Zinc Ions from Bis(thiosemicarbazonato) Complexes Reduces Levels of Alzheimer Disease Amyloid-β Peptide
Journal of Biological Chemistry·2007·193 cit.·DOI
9
Lifelong accumulation of bone in mice lacking <i>Pten</i> in osteoblasts
Proceedings of the National Academy of Sciences·2007·192 cit.·DOI
10
Anti‐PD‐1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases
Cancer Medicine·2018·187 cit.·DOI